Surgery Websites
Wang Lab »  People »  Lab Alumni »  Shant Vartanian, M.D.
Shant Vartanian, M.D.

Shant Vartanian, M.D.

Associate Professor of Surgery
Division of Vascular & Endovascular Surgery



Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
Shant.Vartanian@ucsf.edu
Open Popup

Education

  • 1994-98, Stanford University, B.Sc. (HON) Biological Sciences
  • 1999-03, Saint Louis University, Doctor of Medicine

Residencies

  • 2003-04, University of California, San Francisco, Intern, General Surgery
  • 2004-09, University of California, San Francisco, Resident, General Surgery
  • 2005-07, University of California, San Francisco, Post-Doctoral Research Fellow, Laboratory for Accelerated Vascular Research
  • 2009-10, University of California, San Francisco, Chief Resident, General Surgery

Fellowships

  • 2010-2012, University of California, San Francisco, Fellow, Vascular Surgery

Board Certifications

  • American Board of Surgery, 2011

Clinical Expertise

  • Abdominal Aortic Aneurysm
  • Aortic Dissection
  • Carotid Artery Disease
  • Complex Limb Revascularization
  • Critical Limb Ischemia
  • Diabetic Vascular Disease
  • Dialysis Access
  • Endovascular Aneurysm Repair
  • Mesenteric Artery Disease
  • Peripheral Artery Disease
  • Thoracic Aortic Aneurysm
  • Thoracic Outlet Syndrome

Research Interests

  • Comparative effectiveness of endovacular interventions for lower extremity arterial disease
  • Endovascular interventions for acute and chronic aortic conditions

Biography

Shant Vartanian, M.D. is an assistant professor in the Division of Vascular and Endovascular Surgery. He has been with UCSF since 2003, completing his residency in General Surgery and a fellowship in Vascular Surgery.

He has played a leading role in the revitalization of the Vascular Surgery program at ZSFG. The rapidly maturing program routinely handles aortic trauma, complex endovascular interventions and is a busy clinical practice offering care for peripheral vascular and venous disorders for San Francisco Health Network (SFHN) patients. Dr. Vartanian started and is the medical director of the Vascular Lab, which performs over 1200 non-invasive diagnostic studies for the ZSFG community annually. His clinical research is focused on comparative effectiveness, quality improvement for dialysis access and innovations in dialysis access delivery.

Research Overview

Dr. Vartanian is interested in comparing the effectiveness of endovascular treatments for peripheral arterial disease. By understanding the safety, effectiveness, and cost of each intervention, the aim of the research is to assist patients and clinicians in making informed decisions about treatment options.

Publications

Most recent publications from a total of 25
  1. Ramirez JL, Zarkowsky DS, Sorrentino TA, Hicks CW, Vartanian SM, Gasper WJ, Conte MS, Iannuzzi JC. Antegrade common femoral artery closure device use is associated with decreased complications. J Vasc Surg. 2020 Mar 09. View in PubMed
  2. Zarkowsky DS, Wu B, Gray AT, Oskowitz AZ, Vartanian SM. Functional outcomes of arteriovenous fistulas recruited with regional anesthesia. J Vasc Surg. 2020 Feb; 71(2):584-591.e1. View in PubMed
  3. Subbaraj L, Beleniski F, Courtier J, Vartanian S, Nijagal A. Congenital superior mesenteric artery aneurysm in a 6-week-old infant presenting with upper gastrointestinal bleeding. J Vasc Surg. 2019 Aug 07. View in PubMed
  4. Cedarbaum E, Ma Y, Scherzer R, Price JC, Adimora AA, Bamman M, Cohen M, Fischl MA, Matsushita K, Ofotokun I, Plankey M, Seaberg EC, Yin MT, Grunfeld C, Vartanian S, Sharma A, Tien PC. Contributions of HIV, hepatitis C virus, and traditional vascular risk factors to peripheral artery disease in women. AIDS. 2019 Nov 01; 33(13):2025-2033. View in PubMed
  5. Iqbal Z, Kim S, Moyer J, Moses W, Abada E, Wright N, Kim EJ, Park J, Fissell WH, Vartanian S, Roy S. In vitro and in vivo hemocompatibility assessment of ultrathin sulfobetaine polymer coatings for silicon-based implants. J Biomater Appl. 2019 Aug; 34(2):297-312. View in PubMed
  6. Kaushik S, Gasper WJ, Ramanan B, Vartanian SM, Reilly LM, Chuter TAM, Hiramoto JS. The impact of prior aortic surgery on outcomes after multibranched endovascular aortic aneurysm repair. J Vasc Surg. 2018 08; 68(2):325-330. View in PubMed
  7. Rich NC, Vartanian SM, Sharief S, Freitas DJ, Tuot DS. A mixed-methods investigation of incident Hemodialysis access in a safety-net population. BMC Nephrol. 2017 Sep 02; 18(1):279. View in PubMed
  8. Ramanan B, Ahmed A, Wu B, Causey MW, Gasper WJ, Vartanian SM, Reyzelman AM, Hiramoto JS, Conte MS. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program. J Vasc Surg. 2017 12; 66(6):1765-1774. View in PubMed
  9. Song S, Blaha C, Moses W, Park J, Wright N, Groszek J, Fissell W, Vartanian S, Posselt AM, Roy S. Correction: An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport. Lab Chip. 2017 06 27; 17(13):2334. View in PubMed
  10. Song S, Blaha C, Moses W, Park J, Wright N, Groszek J, Fissell W, Vartanian S, Posselt AM, Roy S. An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport. Lab Chip. 2017 05 16; 17(10):1778-1792. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Shant Vartanian, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

In the News

  • Surgical Innovations Accelerator Projects Harness Unique Talents of MTM Student Teams

    UCSF Surgical Innovations Program - Stacy Kim - October 05, 2017
    Grasp Sm2
    At the heart of the UC Berkeley-UCSF Master of Translational Medicine (MTM) program is a hands-on capstone project, where student teams work on developing medical technologies from idea to bedside. Three Surgical Innovations Accelerator projects from the Spring 2017 cycle have been selected to participate in the program this year: Percutaneous AV Fistula, Tracheostomy Alarm, and Augmented Surgical Vision, adding to a lengthy list of Surgical Innovations (SI) projects that have hosted MTM [...]

  • Accelerator Awards Presented at 2nd Annual Surgical Innovations Shark Tank

    UCSF Surgical Innovations Program - Stacy Kim - April 24, 2017
    IMG_02210
    Six UCSF faculty pitched their medical device ideas to a panel of industry experts for the chance to win seed funding, engineering support, and product development advising at the Surgical Innovations Shark Tank on Tuesday, April 4, 2017 at UCSF's Mission Bay campus. This was the 2nd Shark Tank hosted by Surgical Innovations, an internal incubator/accelerator for early-stage medical devices ideas, and the first to be open to faculty in all UCSF schools and departments. The initiative was [...]

  • Shant Vartanian Receives Accelerator Award to Develop Percutaneous Arteriovenous Fistula Device for Dialysis Access

    UCSF Division of Vascular Surgery - Richard Barg - April 24, 2017
    Shant Vartanian, M.D. received an Accelerator Award to develop a Percutaneous Arteriovenous Fistula Device for Dialysis Access at the Surgical Innovations Shark Tank on Tuesday, April 4, 2017 at UCSF's Mission Bay campus. This was the 2nd Shark Tank hosted by Surgical Innovations, an internal incubator/accelerator for early-stage medical devices ideas, and the first to be open to faculty in all UCSF schools and departments. The initiative was launched 3 years ago by the Department of Surgery [...]

 

 
Site Directory
    X